GE

CAP-ASCCP make recommendations to stadardize histopathologic terminology, guide optimal biomarker use

Monday, September 10, 2012 10:17 AM

A working group from the Lower Anogenital Squamous Terminology (LAST) Standardization Project, an interdisciplinary project led by the College of American Pathologists (CAP) and the American Society for Colposcopy and Cervical Pathology (ASCCP), has published consensus recommendations to standardize the histopathologic terminology for squamous epithelial lesions of the lower anogenital tract associated with human papillomavirus and to guide optimal biomarker use, according to Ventana Medical Systems, a member of the Roche Group.

More... »

Codexis appoints David O’Toole as CFO

Wednesday, September 5, 2012 11:08 AM

Codexis, a Redwood City, Calif.-based developer of cost-advantaged processes for the production of biofuels, bio-based chemicals and pharmaceuticals, has appointed David O’Toole as senior vice president and CFO.

More... »

GE Healthcare launches modular biopharmaceutical factory, KUBio

Wednesday, September 5, 2012 10:26 AM

GE Healthcare, the healthcare business of GE, has launched KUBio, an innovative off-the-shelf, modular factory designed to save manufacturers of biopharmaceuticals both time and money.

More... »

Icon forms partnership with University College Dublin

Wednesday, September 5, 2012 10:13 AM

Icon,a global provider of outsourced development services, has entered into a strategic partnership with University College Dublin (UCD), Ireland’s largest third-level institution.

More... »

Assay Depot, Genspace team up for Open Science Challenge

Tuesday, September 4, 2012 12:32 PM

Assay Depot of San Diego and New York-based Genspace have launched the Tri-State Open Science Challenge, a science competition open to citizen scientists and bioartists who want to translate their ideas into reality. Three projects will receive $5,000 in research funding and a one-year membership to Genspace, a community biotechnology laboratory in Brooklyn, NY. One under-18 project will receive $1,000 in research funding.

More... »

Soligenix reports positive phase Ib results with Ricin toxin vaccine

Tuesday, September 4, 2012 08:43 AM

Soligenix, a development stage biopharmaceutical company based in Princeton, N.J., released results of a phase Ib trial of an aluminum hydroxide (Alum) adjuvanted formulation of RiVax, designed to improve the immunogenicity of the vaccine.

More... »

Y-Prime names Greef as senior business analyst

Thursday, August 30, 2012 02:53 PM

Y-Prime Technologies, an Malvern, Penn.-based eClinical products and life sciences consulting services company, has expanded its international operations in Europe and has named Jeanette Anne Greef as senior business analyst in the U.K. office.

More... »

Charles River acquires Accugenix

Thursday, August 30, 2012 10:35 AM

Charles River Laboratories International, a global provider of research products and services, has acquired Accugenix, a global provider of cGMP-compliant contract microbial identification testing, for approximately $17 million in cash.

More... »

Oxygen Biotherapeutics relocating R&D function to North Carolina

Wednesday, August 29, 2012 10:04 AM

Oxygen Biotherapeutics, a Morrisville, N.C.-based developer of medical and cosmetic products that efficiently deliver oxygen to tissues in the body, is searching for laboratory space in the Research Triangle Park region of North Carolina.

More... »

Pascal Soriot named AstraZeneca CEO

Tuesday, August 28, 2012 03:06 PM

AstraZeneca has announced Pascal Soriot’s appointment as the company’s chief executive officer. He will assume the new role and join the AstraZeneca board as an executive director as of Oct. 1.

More... »